Award recordCONTRACT

CSL BEHRING L.L.C.

PIID VA24916J1881· VHA· 596-LEXINGTON· 6505 · DRUGS AND BIOLOGICALS· FY2016· $2,278 net obligations· UEI H3WKVE9VBLY3· PA

Description

K-CENTRA

First action · last action
2016-03-16 · 2016-03-16
Transactions
2
First transaction's obligation
$2,193
Base + all options value (sum of deltas)
$2,278
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$2,278$0Base award · 2016-03-16 · this action $2,193 · running total $2,193Modification P00001 · 2016-03-16 · this action $84 · running total $2,278
  • Base2016-03-16+$2,193= $2,193
  • Mod P000012016-03-16+$84= $2,278
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-03-16+$2,193$2,193K-CENTRA
Mod P00001· FUNDING ONLY ACTION2016-03-16+$84$2,278K-CENTRA

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under 6505 from 596-LEXINGTON (most recent first)

AwardRecipientOfficeNet obligationsFY
VA24916J1974GRIFOLS BIOLOGICALS LLC596-LEXINGTON$9,262FY2016
VA24916J1721EISAI INC.596-LEXINGTON$10,441FY2016
VA24916J1176EISAI INC.596-LEXINGTON$10,441FY2016
VA24916J0609EISAI INC.596-LEXINGTON$10,442FY2016
VA24916P0254BIOLOGICS, INC.596-LEXINGTON$10,442FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24916J1881_3600_-NONE-_-NONE- · retrieved 2026-09-26.